Inactive Instrument
Abliva AB Stock
Stocks
ABLI
SE0002575340
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +0.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 59 | 2014-01-09 | |
Dag Nesse
CTO | Chief Tech/Sci/R&D Officer | 60 | 2023-01-31 |
Magnus Hansson
CTO | Chief Tech/Sci/R&D Officer | 50 | 2015-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 2017-11-05 | |
| Director/Board Member | 66 | 2017-04-26 | |
David Bejker
BRD | Director/Board Member | 51 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/7/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 3/7/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 2/12/25 | Sell | Chief Technology Officer | 3,104,000 | 0.1926% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -1.11% | - | - | 76M | |
| -2.11% | -1.68% | +44.52% | +95.15% | 68.24B | |
| -0.23% | -4.45% | +30.39% | +73.64% | 62.23B | |
| +1.67% | +2.47% | -11.23% | +388.34% | 27.8B | |
| -1.05% | -4.43% | +30.56% | +10.07% | 24.86B | |
| +0.34% | -6.78% | -7.27% | -17.99% | 24.22B | |
| +0.43% | -3.37% | +14.85% | -19.29% | 19.36B | |
| -3.03% | -2.29% | +185.12% | +334.07% | 17.28B | |
| -1.94% | -4.94% | -5.29% | +495.65% | 14.46B | |
| -2.28% | -4.90% | +43.64% | +155.21% | 14.23B | |
| Average | -0.80% | -3.77% | +36.14% | +168.32% | 30.3B | |
| Weighted average by Cap. | -0.86% | -3.31% | +33.86% | +133.71% |
Employees
6
